| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1658 | 88 | 72 | 15 |
The journal tackles a plethora of topics, such as Internal medicine, Pharmacotherapy, Cardiology, Intensive care medicine and Endocrinology. The study on Internal medicine presented in it intersects with the topics under Diabetes mellitus. The Pharmacotherapy works featured in the journal incorporate elements from Clinical trial, Surgery, Statin, Disease and Pharmacology toxicology.
In addition to Statin research, it aims to explore topics under Simvastatin and Atorvastatin. Percutaneous coronary intervention, Coronary artery disease, Atrial fibrillation, Ejection fraction and Clopidogrel are among the concentrations of Cardiology that garnered much attention in American Journal of Cardiovascular Drugs. Conventional PCI and Acute coronary syndrome are some topics wherein Percutaneous coronary intervention research discussed in it have an impact.
The Endocrinology study tackled is a key component of adjacent topics in the area of Pharmacology. Randomized controlled trial research presented in it encompasses a variety of subjects, including Anesthesia, Placebo and Adverse effect. Research on Stroke addressed in American Journal of Cardiovascular Drugs frequently intersections with the field of Warfarin.
The published papers generally zeroe in on subjects such as Internal medicine, Endocrinology, Cardiology, Pharmacotherapy and Pharmacology. The studies on Internal medicine discussed at the most cited articles can also contribute to research in the domains of Diabetes mellitus and Gastroenterology. The most cited papers explore issues in Pharmacotherapy which can be linked to other research areas like Regimen, Surgery, Adverse effect, Intensive care medicine and Physical therapy.
The journal mainly deals with areas of study such as Internal medicine, Pharmacotherapy, Cardiology, Randomized controlled trial and Intensive care medicine. Internal medicine, which encompasses Heart failure, Atrial fibrillation, Myocardial infarction, Stroke and Adverse effect, is the main subject of American Journal of Cardiovascular Drugs. While it focused on Pharmacotherapy, it was also able to explore topics like Clinical trial, Coronary artery disease, Disease, Aspirin and Pharmacology toxicology.
American Journal of Cardiovascular Drugs focuses on Clinical trial but the discussions also offer insight into other areas such as Heparin and Angina. The research on Cardiology tackled can also make contributions to studies in the areas of Clinical endpoint and Blood pressure. The journal explores research in Intensive care medicine alongside concepts in Risk factor and other areas of study in Cause of death.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in American Journal of Cardiovascular Drugs (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in American Journal of Cardiovascular Drugs (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 3.57% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.75% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.05% of all publications and 48.15% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
An often overlooked aspect of scientific research is the potential careers it can lead to. For healthcare professionals looking to specialize in cardiovascular drugs' research and treatment, having a deep understanding of the subject matter discussed in the American Journal of Cardiovascular Drugs could be a stepping stone towards a gratifying vocation. There are diverse career paths that stem from this field. Academic and research roles in universities and research institutions often require an in-depth knowledge of various topics covered in the journal. This could lead to opportunities for postdoctoral research, lecturing, and eventually, professorial positions. In addition, the healthcare industry offers roles in pharmaceutical companies, hospitals, and clinics. Roles such as Clinical Pharmacologist, Cardiologist, Cardiovascular Surgeon, and Nurse Practitioner are common. In particular, the role of a Nurse Practitioner specializing in Cardiology demands a strong understanding of cardiovascular pharmacotherapies. For those willing to take up the challenge, they might find enrolling in one of the {anchor} beneficial. Further, roles in government institutions and regulatory bodies such as the Food and Drug Administration (FDA) or the National Institutes of Health (NIH) could also be explored. Experts in cardiovascular drugs may advise on healthcare policies, contribute to drug approval processes, and execute public health initiatives. In summary, the field of cardiovascular drugs' research is diverse and growing. Opportunities abound for those with the skills and knowledge to navigate this complex yet rewarding discipline.
Namrata Singhania;Saurabh Bansal;Divya P. Nimmatoori;Abutaleb A. Ejaz
(2020)Dhrubajyoti Bandyopadhyay;Tauseef Akhtar;Adrija Hajra;Manasvi Gupta
(2020)Jolien Neefs;Nicoline W E van den Berg;Sébastien P J Krul;S Matthijs Boekholdt
(2020)Subuhi Kaul;Manasvi Gupta;Dhrubajyoti Bandyopadhyay;Adrija Hajra
(2021)Gilles Montalescot;Carlos Brotons;Bernard Cosyns;Harry J. Crijns
(2020)Daniel M. F. Claassens;Pim W. M. van Dorst;Gerrit J. A. Vos;Thomas O. Bergmeijer
(2021)Fabian Sanchis-Gomar;Fabian Sanchis-Gomar;Carl J. Lavie;Daniel P. Morin;Carme Perez-Quilis
(2020)Raj M Khandwalla;Daniel Grant;Kade Birkeland;J Thomas Heywood
(2021)Atul Pathak;Neil R. Poulter;Michael Kavanagh;Reinhold Kreutz
(2021)Pursuing a career in medicine often opens doors to diverse educational options beyond traditional medical degrees. Many students and professionals explore specialized online programs to enhance their skills or pivot within the healthcare field.
For those interested in nutrition and wellness, an online nutritionist degree offers a flexible path to becoming a certified nutrition specialist. This option provides foundational knowledge in dietetics and health, perfect for supplementing a medical background or pursuing preventive care roles.
Nurses aiming to expand their clinical expertise can benefit from rn to bsn online no clinicals programs. These options allow working professionals to earn a Bachelor of Science in Nursing without additional clinical requirements, making it easier to advance their careers while managing existing responsibilities.
Healthcare leadership is another growing area. Accelerated paths such as the accelerated healthcare management degree online enable students to quickly gain management skills tailored to healthcare systems, preparing them for administrative or executive roles.
For nurses specializing in mental health, psych nurse practitioner programs provide advanced training in psychiatric care. These programs equip practitioners to meet the growing demand for mental health services across diverse populations.
